Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation

Aim: Comparison of the effectiveness of strontium ranelate (SR) and alendronate sodium (AS) on bone mineral density (BMD) in postmenopausal osteoporosis. Material and Methods: A total of 41 patients were included in the study. 2 gr/day SR was applied a group (SR, n=21), while the other group recei...

Full description

Bibliographic Details
Main Authors: Kurtuluş Kaya, Sibel Ünsal Delialioğlu, Sumru Özel, Canan Çulha, Eda Kurt, Sezen Özgönül
Format: Article
Language:English
Published: Galenos Yayinevi 2009-12-01
Series:Türk Osteoporoz Dergisi
Subjects:
Online Access:http://www.turkosteoporozdergisi.org/article_4064/Comparison-Of-Effectiveness-Of-Strontium-Ranelate-And-Alendronate-Sodium-In-Postmenopausal-Osteoporosis-Original-Investigation
id doaj-14db6f71e9d74e26ae64cf8bda58194b
record_format Article
spelling doaj-14db6f71e9d74e26ae64cf8bda58194b2020-11-25T04:10:32ZengGalenos YayineviTürk Osteoporoz Dergisi2147-26532009-12-011537074Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original InvestigationKurtuluş Kaya0Sibel Ünsal Delialioğlu1Sumru Özel2Canan Çulha3Eda Kurt4Sezen Özgönül5Tatvan Devlet Hastanesi, BitlisAnkara Fizik Tedavi Rehabilitasyon E¤itim ve Araflt›rma Hastanesi, 3. Fizik Tedavi ve Rehabilitasyon Kliniği, AnkaraAnkara Fizik Tedavi Rehabilitasyon E¤itim ve Araflt›rma Hastanesi, 3. Fizik Tedavi ve Rehabilitasyon Kliniği, AnkaraAnkara Fizik Tedavi Rehabilitasyon E¤itim ve Araflt›rma Hastanesi, 3. Fizik Tedavi ve Rehabilitasyon Kliniği, AnkaraAnkara Fizik Tedavi Rehabilitasyon E¤itim ve Araflt›rma Hastanesi, 3. Fizik Tedavi ve Rehabilitasyon Kliniği, AnkaraAnkara Fizik Tedavi Rehabilitasyon Eğitim ve Araştırma Hastanesi, 2. Fizik Tedavi ve Rehabilitasyon Kliniği, Ankara, TürkiyeAim: Comparison of the effectiveness of strontium ranelate (SR) and alendronate sodium (AS) on bone mineral density (BMD) in postmenopausal osteoporosis. Material and Methods: A total of 41 patients were included in the study. 2 gr/day SR was applied a group (SR, n=21), while the other group received 70 mg/week AS randomly (AS, n=20). Both groups received daily doses of 1200 mg calcium+800 IU vitamin D3. BMD was measured before treatment (BT) and at the 6th and 12th months after treatment (AT) using dual energy x-ray absorptiometry. Lumbar spine (L2-L4), femoral neck and femoral total BMD values were recorded. 15 of the patients who received SR treatment (n=21) came for AT 6th month, and 17 of them came for AT 12th month follow-up, while 10 of patients receiving AS treatment (n=20) came for AT 6th month, and 7 came for AT 12th month follow-up. On the other hand, twenty patients (SR n=13, AS n=7) came for both 6th and 12th month follow-up. Results: Age, body mass index, and BT BMD values in all regions were similar (p>0.05). When BMD values at AT6th and AT12th months were compared with BT values, it was found that SR produced significant increases in BMD values of all regions examined (p<0.05); and that AS produced significant increase at femoral neck and lumbar spine BMD values (p<0.05) while it did not produced significant increase in femoral total BMD values. No significant difference was found between two groups with respect to BMD values between AT6th and AT12th months (p>0.05). Conclusion: It has been found that both SR and AS produced significant increases in femoral neck and lumbar spine BMD values at AT12th months, while SR is found to be more effective than AS on femoral total BMD values. (From the World of Osteoporosis 2009;15:70-4)http://www.turkosteoporozdergisi.org/article_4064/Comparison-Of-Effectiveness-Of-Strontium-Ranelate-And-Alendronate-Sodium-In-Postmenopausal-Osteoporosis-Original-InvestigationStrontium ranelatealendronate sodiumpostmenopausal osteoporosis
collection DOAJ
language English
format Article
sources DOAJ
author Kurtuluş Kaya
Sibel Ünsal Delialioğlu
Sumru Özel
Canan Çulha
Eda Kurt
Sezen Özgönül
spellingShingle Kurtuluş Kaya
Sibel Ünsal Delialioğlu
Sumru Özel
Canan Çulha
Eda Kurt
Sezen Özgönül
Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
Türk Osteoporoz Dergisi
Strontium ranelate
alendronate sodium
postmenopausal osteoporosis
author_facet Kurtuluş Kaya
Sibel Ünsal Delialioğlu
Sumru Özel
Canan Çulha
Eda Kurt
Sezen Özgönül
author_sort Kurtuluş Kaya
title Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
title_short Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
title_full Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
title_fullStr Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
title_full_unstemmed Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
title_sort comparison of effectiveness of strontium ranelate and alendronate sodium in postmenopausal osteoporosis - original investigation
publisher Galenos Yayinevi
series Türk Osteoporoz Dergisi
issn 2147-2653
publishDate 2009-12-01
description Aim: Comparison of the effectiveness of strontium ranelate (SR) and alendronate sodium (AS) on bone mineral density (BMD) in postmenopausal osteoporosis. Material and Methods: A total of 41 patients were included in the study. 2 gr/day SR was applied a group (SR, n=21), while the other group received 70 mg/week AS randomly (AS, n=20). Both groups received daily doses of 1200 mg calcium+800 IU vitamin D3. BMD was measured before treatment (BT) and at the 6th and 12th months after treatment (AT) using dual energy x-ray absorptiometry. Lumbar spine (L2-L4), femoral neck and femoral total BMD values were recorded. 15 of the patients who received SR treatment (n=21) came for AT 6th month, and 17 of them came for AT 12th month follow-up, while 10 of patients receiving AS treatment (n=20) came for AT 6th month, and 7 came for AT 12th month follow-up. On the other hand, twenty patients (SR n=13, AS n=7) came for both 6th and 12th month follow-up. Results: Age, body mass index, and BT BMD values in all regions were similar (p>0.05). When BMD values at AT6th and AT12th months were compared with BT values, it was found that SR produced significant increases in BMD values of all regions examined (p<0.05); and that AS produced significant increase at femoral neck and lumbar spine BMD values (p<0.05) while it did not produced significant increase in femoral total BMD values. No significant difference was found between two groups with respect to BMD values between AT6th and AT12th months (p>0.05). Conclusion: It has been found that both SR and AS produced significant increases in femoral neck and lumbar spine BMD values at AT12th months, while SR is found to be more effective than AS on femoral total BMD values. (From the World of Osteoporosis 2009;15:70-4)
topic Strontium ranelate
alendronate sodium
postmenopausal osteoporosis
url http://www.turkosteoporozdergisi.org/article_4064/Comparison-Of-Effectiveness-Of-Strontium-Ranelate-And-Alendronate-Sodium-In-Postmenopausal-Osteoporosis-Original-Investigation
work_keys_str_mv AT kurtuluskaya comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
AT sibelunsaldelialioglu comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
AT sumruozel comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
AT cananculha comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
AT edakurt comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
AT sezenozgonul comparisonofeffectivenessofstrontiumranelateandalendronatesodiuminpostmenopausalosteoporosisoriginalinvestigation
_version_ 1724420373101936640